Immunome GAAP EPS of -$2.43 misses by $0.16, revenue of $6.9M misses by $0.8M
Source: SeekingAlpha
2026-03-03 16:38:47 ET
More on Immunome
- Immunome: Maintaining "Strong Buy" On Successful RINGSIDE Trial With Varegacestat
- Immunome announces proposed public offering
- Seeking Alpha’s Quant Rating on Immunome
- Historical earnings data for Immunome
- Financial information for Immunome
Read the full article on Seeking Alpha
For further details see:
Immunome GAAP EPS of -$2.43 misses by $0.16, revenue of $6.9M misses by $0.8M
Immunome Inc.
NASDAQ: IMNM
IMNM Trading
6.37% G/L:
$21.89 Last:
277,121 Volume:
$21.33 Open:
IMNM Latest News
March 04, 2026 12:32:46 pm
Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing
March 03, 2026 04:02:00 pm
Immunome Reports Full Year 2025 Financial Results and Provides Business Update
February 22, 2026 01:23:29 pm
Biotech-Focused Fund Adds $12 Million to Immunome Bet as Stock Surges 120%
IMNM Stock Data
$2,743,955,547
101,847,421
0.64%
55
N/A
Biotechnology & Life Sciences
Healthcare
US
Bothell
